Peptide Therapy Cost: What You'll Actually Pay in 2026

Cost by Peptide: A Comparison Table

The table below shows approximate monthly cost ranges for the most commonly used peptides. These ranges reflect what patients have reported paying through various access methods, from compounding pharmacies to research suppliers. Actual costs will vary depending on your provider, dosing protocol, and source.

Important: These ranges are approximate and reflect a snapshot in time. Prices change as regulatory status, supply chains, and competition shift. The ranges above are meant to give a realistic starting point for budgeting, not a guarantee of what you will pay.

Cost by Access Method

Where you get your peptides matters as much as which peptide you choose. The three main access methods each come with different cost profiles, quality controls, and risk levels.

The right access method depends on your risk tolerance, budget, and whether you already have a prescriber. For the regulatory context on what is currently legal, see are peptides legal.

Insurance Coverage: What to Expect

The short answer is that insurance almost never covers compounded peptide therapy. Here is why:

• Compounded drugs are not FDA-approved. Most insurance plans only cover FDA-approved medications, and none of the commonly used compounded peptides (BPC-157, TB-500, growth hormone secretagogues) have gone through the FDA drug-approval process.
• Off-label use is rarely covered for compounded products. Even when an insurer covers off-label use of an FDA-approved drug, that logic does not extend to compounded peptides, which are not FDA-approved in the first place.
• Exceptions exist but are rare. Some FDA-approved peptide drugs — such as certain GLP-1 receptor agonists for diabetes — are covered by insurance because they went through the standard approval process. These are distinct from the compounded peptides discussed in this guide.

For most patients, peptide therapy is an out-of-pocket expense. Some providers accept HSA or FSA payments, which can reduce the effective cost by using pre-tax dollars. Ask your provider before assuming any coverage.

Hidden Costs: What the Headline Price Doesn't Include

The per-vial or per-month price of a peptide is not the full cost. Here are the additional expenses most patients encounter:

• Physician consultation: An initial consultation with a prescriber who offers peptide therapy typically costs $150 to $400, with follow-up visits ranging from $75 to $200. Some telehealth platforms — such as Hims — bundle this into a monthly subscription.
• Lab work: Most responsible prescribers require baseline blood work before starting peptide therapy and periodic monitoring during treatment. Depending on the panel, labs cost $100 to $500 per draw if not covered by insurance (some basic panels may be covered).
• Bacteriostatic water: Injectable peptides require reconstitution with bacteriostatic water, which typically costs $5 to $15 per vial. Some compounding pharmacies include it; others do not.
• Syringes and supplies: Insulin syringes for subcutaneous injection run $10 to $25 for a box of 100. Alcohol swabs and sharps containers add a few dollars per month.
• Shipping: Compounded peptides often require cold shipping, which can add $10 to $30 per order depending on the pharmacy.

All told, the ancillary costs can add $50 to $150 per month on top of the peptide itself, especially in the first month when consultation and labs are due. Budget accordingly.

The Wolverine Stack: Combined Cost Breakdown

The Wolverine Stack — BPC-157 and TB-500 taken together — is one of the most popular peptide protocols for injury recovery and tissue repair. Here is what the full cost picture looks like:

• Peptides alone: $200 to $400 per month for the combination, depending on dosing and source. Some compounders offer a bundled vial at a lower cost than purchasing each separately.
• With physician oversight: Add $75 to $200 per month for ongoing consultations (prorated from initial plus follow-ups).
• With labs and supplies: Add $50 to $100 per month averaged across the treatment period.
• Realistic all-in range: $300 to $700 per month for a supervised Wolverine Stack protocol through a compounding pharmacy.

The research-chemical route is significantly cheaper on the headline number — potentially $60 to $150 per month for both peptides — but comes with the quality and safety trade-offs described in the access-method section above.

How the 2026 Regulatory Vote May Change Pricing

The July 2026 Pharmacy Compounding Advisory Committee vote, which recommended restoring compounding access for BPC-157, TB-500, KPV, Epitalon, and Semax, could meaningfully affect pricing if the FDA's final decision is favorable. Here is the logic:

• More compounders = more competition. When access is restricted, the few pharmacies still willing to compound these peptides have less price competition. If access is formally restored, more pharmacies will enter the market, which historically drives prices down.
• Lower legal risk reduces supplier costs. Part of the current pricing premium reflects the legal uncertainty compounders face. A clear regulatory green light removes that risk premium.
• Research-chemical demand may drop. If compounded peptides become readily available again at competitive prices, fewer patients will turn to unregulated research suppliers, which could also reduce demand-side pricing pressure in that market.
• Telehealth platforms may expand offerings. Platforms that removed certain peptides from their formularies during the restriction period may add them back, increasing convenience and price competition in the telemedicine channel.

None of this is guaranteed — it depends entirely on the FDA's final decision and how quickly compounders ramp up production. For the full regulatory timeline, see our peptide regulation timeline.

How to Reduce Your Peptide Therapy Costs

If you are paying out of pocket — and most people are — here are practical ways to manage the cost:

• Use HSA or FSA funds. If your provider provides a prescription and a letter of medical necessity, you may be able to use pre-tax health savings to cover peptide therapy costs. Confirm with your plan administrator.
• Ask about bundled pricing. Some compounding pharmacies and telehealth platforms offer discounted multi-month packages or bundled stacks (like the Wolverine Stack) at a lower price than buying components separately.
• Compare pharmacy prices. Compounding pharmacy pricing is not standardized. Get quotes from two or three licensed pharmacies before committing — price differences of 30 to 50 percent for the same compound are not unusual.
• Minimize unnecessary labs. Work with your prescriber to determine which labs are truly needed and how often. Some providers order extensive panels more frequently than the clinical situation requires.
• Consider the full cost, not just the peptide price. A telehealth platform that charges more per vial but bundles consultations may be cheaper overall than a low-price pharmacy plus a separate prescriber.

The Bottom Line

Peptide therapy is not cheap, but it is also not as expensive as the highest-end quotes suggest — if you know where to look and what to budget for. Compounded single-peptide protocols typically run $100 to $400 per month for the peptide itself, with ancillary costs adding $50 to $150 on top. Research-grade alternatives cost less upfront but come with significant quality and safety trade-offs.

The biggest variable in the near term is regulation. If the FDA's final decision restores compounding access for the peptides recommended by the July 2026 committee vote, prices are likely to come down as competition increases. For now, the smartest approach is to work with a licensed prescriber, compare pharmacy prices, and budget for the full cost — not just the peptide. For specific compound information, see our pages on BPC-157, TB-500, and the Wolverine Stack. For the broader picture, start with the peptide therapy hub and the are peptides legal FAQ.